Page last updated: 2024-08-17

cycloserine and Autism Spectrum Disorder

cycloserine has been researched along with Autism Spectrum Disorder in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (50.00)24.3611
2020's4 (50.00)2.80

Authors

AuthorsStudies
Boykin, T; Kuhrau, S; Rech, MA1
Burket, JA; Deutsch, SI1
Billiras, RI; Dekeyne, A; Fone, KCF; Gobert, A; Millan, MJ; Rivet, JM; Sicard, DI; Watson, DJG1
Aye, SZ; Mon, ST; Ni, H; Sein, HH; Wong, YKY; Zheng, Q1
Chuang, HC; Hsueh, YP; Huang, TN; Lerch, JP; Qiu, LR; Yen, TL1
Deutsch, SI; Hartmann, K; Manser, P; Okwara, L; Urbano, M1
Erickson, CA; Hurwitz, S; Liu, H; McDougle, CJ; Minshawi, NF; Plawecki, MH; Posey, DJ; Shaffer, R; Swiezy, NB; Wink, LK1
Adams, R; Erickson, CA; Horn, PS; McDougle, CJ; Minshawi, NF; Pedapati, EV; Plawecki, MH; Posey, DJ; Schaefer, TL; Shaffer, RC; Swiezy, NB; Wink, LK1

Reviews

2 review(s) available for cycloserine and Autism Spectrum Disorder

ArticleYear
From Mouse to Man: N-Methyl-d-Aspartic Acid Receptor Activation as a Promising Pharmacotherapeutic Strategy for Autism Spectrum Disorders.
    The Medical clinics of North America, 2023, Volume: 107, Issue:1

    Topics: Animals; Autism Spectrum Disorder; Cycloserine; Dizocilpine Maleate; Humans; Mice; Mice, Inbred BALB C; N-Methylaspartate; Randomized Controlled Trials as Topic; Receptors, N-Methyl-D-Aspartate; Social Behavior

2023
The effectiveness and adverse effects of D-cycloserine compared with placebo on social and communication skills in individuals with autism spectrum disorder.
    The Cochrane database of systematic reviews, 2021, 02-14, Volume: 2

    Topics: Autism Spectrum Disorder; Child; Child, Preschool; Communication; Cycloserine; Female; Humans; Indiana; Male; Multicenter Studies as Topic; Ohio; Patient Dropouts; Placebos; Randomized Controlled Trials as Topic; Social Skills; Stereotyped Behavior

2021

Trials

3 trial(s) available for cycloserine and Autism Spectrum Disorder

ArticleYear
A trial of d-cycloserine to treat the social deficit in older adolescents and young adults with autism spectrum disorders.
    The Journal of neuropsychiatry and clinical neurosciences, 2015, Volume: 27, Issue:2

    Topics: Adolescent; Adult; Antimetabolites; Autism Spectrum Disorder; Cycloserine; Double-Blind Method; Female; Humans; Linear Models; Longitudinal Studies; Male; Mental Status Schedule; Neuropsychological Tests; Psychiatric Status Rating Scales; Social Communication Disorder; Time Factors; Treatment Outcome; Young Adult

2015
A randomized, placebo-controlled trial of D-cycloserine for the enhancement of social skills training in autism spectrum disorders.
    Molecular autism, 2016, Volume: 7

    Topics: Autism Spectrum Disorder; Behavior Therapy; Child; Child, Preschool; Cycloserine; Double-Blind Method; Excitatory Amino Acid Agonists; Female; Humans; Interpersonal Relations; Learning; Male; Parents; Severity of Illness Index; Social Skills; Treatment Failure

2016
d-Cycloserine enhances durability of social skills training in autism spectrum disorder.
    Molecular autism, 2017, Volume: 8

    Topics: Autism Spectrum Disorder; Child; Child, Preschool; Cycloserine; Double-Blind Method; Drug Administration Schedule; Female; Humans; Learning; Male; Severity of Illness Index; Social Behavior; Treatment Outcome

2017

Other Studies

3 other study(ies) available for cycloserine and Autism Spectrum Disorder

ArticleYear
D-Cycloserine-Induced Seizure Activity in the Emergency Department: A Case Report.
    Journal of pharmacy practice, 2023, Volume: 36, Issue:3

    Topics: Anticonvulsants; Autism Spectrum Disorder; Cycloserine; Emergency Service, Hospital; Humans; Seizures

2023
Comparative Pro-cognitive and Neurochemical Profiles of Glycine Modulatory Site Agonists and Glycine Reuptake Inhibitors in the Rat: Potential Relevance to Cognitive Dysfunction and Its Management.
    Molecular neurobiology, 2020, Volume: 57, Issue:5

    Topics: Amino Acids; Animals; Autism Spectrum Disorder; Cognition; Cognition Disorders; Cycloserine; Dose-Response Relationship, Drug; Freezing Reaction, Cataleptic; Glycine; Glycine Agents; Male; Memory, Short-Term; Motor Activity; Neurotransmitter Uptake Inhibitors; Nootropic Agents; Prefrontal Cortex; Rats; Rats, Wistar; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate; Recognition, Psychology; Sarcosine; Schizophrenia; Scopolamine; Serine; Social Behavior

2020
Haploinsufficiency of autism causative gene
    Molecular autism, 2019, Volume: 10

    Topics: Animals; Autism Spectrum Disorder; Cycloserine; Discrimination, Psychological; DNA-Binding Proteins; Haploinsufficiency; Male; Mice; Mice, Inbred C57BL; Neurons; Olfactory Bulb; Olfactory Perception; Receptors, N-Methyl-D-Aspartate; Smell; T-Box Domain Proteins

2019